Holen Sie sich die Stockscreener-App
5.44
0.28%
0.03
Schlusskurs vom Vortag:
$5.41
Offen:
$5.35
24-Stunden-Volumen:
71,332
Relative Volume:
0.65
Marktkapitalisierung:
$310.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-66.86M
KGV:
-4.5333
EPS:
-1.2
Netto-Cashflow:
$-58.82M
1W Leistung:
+13.26%
1M Leistung:
+34.95%
6M Leistung:
+15.92%
1J Leistung:
+10.26%
1-Tages-Spanne:
$5.235
$5.50
1-Wochen-Bereich:
$4.68
$5.50
52-Wochen-Spanne:
$2.60
$7.77
Design Therapeutics Inc Stock (DSGN) Company Profile
Firmenname
Design Therapeutics Inc
Sektor
Branche
Telefon
858-293-4900
Adresse
6005 HIDDEN VALLEY ROAD, CARLSBAD
Vergleichen Sie DSGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DSGN
Design Therapeutics Inc
|
5.45 | 296.13M | 0 | -66.86M | -58.82M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.38 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.18 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.03 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
704.50 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
299.80 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Design Therapeutics Inc Stock (DSGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-14 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-08-15 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-08-15 | Herabstufung | SVB Securities | Outperform → Market Perform |
| 2023-08-15 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-05-04 | Hochstufung | Goldman | Sell → Neutral |
| 2022-06-10 | Eingeleitet | Wedbush | Outperform |
| 2022-05-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-01-19 | Eingeleitet | Goldman | Sell |
| 2021-04-20 | Eingeleitet | Goldman | Neutral |
| 2021-04-20 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Design Therapeutics Inc Aktie (DSGN) Neueste Nachrichten
Clinical-Stage Biotech Design Therapeutics to Share Updates at 2025 Cantor Healthcare Conference in NYC - Stock Titan
Visual trend scoring systems applied to Design Therapeutics Inc.Weekly Profit Report & AI Powered Market Trend Analysis - Newser
How to use a screener to detect Design Therapeutics Inc. breakouts2025 Winners & Losers & Verified Technical Signals - Newser
Historical volatility pattern of Design Therapeutics Inc. visualizedAnalyst Upgrade & Community Supported Trade Ideas - Newser
Will Design Therapeutics Inc. rebound enough to break evenTrade Risk Summary & Daily Stock Trend Watchlist - Newser
Risk vs reward if holding onto Design Therapeutics Inc.Trade Entry Report & Free Low Drawdown Momentum Trade Ideas - Newser
Combining machine learning predictions for Design Therapeutics Inc.Weekly Volume Report & AI Forecast for Swing Trade Picks - Newser
Using flow based indicators on Design Therapeutics Inc.2025 Investor Takeaways & Community Consensus Picks - Newser
Can a trend reversal in Design Therapeutics Inc. lead to recoveryQuarterly Risk Review & AI Optimized Trading Strategy Guides - Newser
Smart tools for monitoring Design Therapeutics Inc.’s price actionWeekly Gains Summary & Real-Time Volume Spike Alerts - Newser
Will Design Therapeutics Inc. stock recover after recent dropJuly 2025 Catalysts & Smart Allocation Stock Reports - Newser
Using data models to predict Design Therapeutics Inc. stock movementForecast Cut & Long-Term Growth Plans - Newser
What high frequency data says about Design Therapeutics Inc.Market Volume Report & Technical Analysis for Trade Confirmation - Newser
Can volume confirm reversal in Design Therapeutics Inc.Weekly Stock Recap & Accurate Entry/Exit Alerts - Newser
Can technical indicators confirm Design Therapeutics Inc.’s reversalJuly 2025 Review & High Conviction Investment Ideas - Newser
Will Design Therapeutics Inc. continue its uptrendJuly 2025 Retail & Free Reliable Trade Execution Plans - Newser
Why Design Therapeutics Inc. is moving today2025 Market Sentiment & AI Optimized Trade Strategies - Newser
How to build a custom watchlist for Design Therapeutics Inc.2025 Retail Activity & Safe Entry Point Alerts - Newser
Design Therapeutics Inc. Moves Into Overbought Range Analysts CautiousJuly 2025 News Drivers & Community Verified Swing Trade Signals - beatles.ru
Design Therapeutics Inc.’s Beta Climbs After Market VolatilityJuly 2025 Review & Growth Focused Stock Pick Reports - newsyoung.net
Will a bounce in Design Therapeutics Inc. offer an exitWeekly Earnings Recap & Real-Time Stock Price Movement Reports - Newser
Backtesting results for Design Therapeutics Inc. trading strategiesBuy Signal & Precise Swing Trade Alerts - Newser
Design Therapeutics Sees Increased R&D Expenses Amid $36.8M Net Loss - AInvest
Design Therapeutics Reports Increased R&D Expenses Amid Net Loss - TipRanks
What technical models suggest about Design Therapeutics Inc.’s comebackJuly 2025 Sector Moves & Consistent Profit Trade Alerts - Newser
Price action breakdown for Design Therapeutics Inc.2025 Price Momentum & Risk Controlled Stock Alerts - Newser
Using Bollinger Bands to evaluate Design Therapeutics Inc.Quarterly Profit Summary & Smart Allocation Stock Reports - Newser
Watch for Trend Continuation in Design Therapeutics Inc. Next Week2025 Valuation Update & Accurate Intraday Trade Tips - thegnnews.com
Design Therapeutics (NASDAQ:DSGN) Trading Up 1.3% – Time to Buy? - Defense World
Finanzdaten der Design Therapeutics Inc-Aktie (DSGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
9.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):